Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Safety and Tolerability of Single-dose Human Umbilical Cord Mesenchymal Stem Cell (IxCell hUC-MSC-S) in Patients With Convalescent Phase of Ischemic Stroke

NCT05697718 is registered in ClinicalTrials.gov with Shanghai IxCell Biotechnology Co., LTD as lead sponsor.

NCT NCT05697718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05697718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Safety and Tolerability of Single-dose Human Umbilical Cord Mesenchymal Stem Cell (IxCell hUC-MSC-S) in Patients With Convalescent Phase of Ischemic Stroke
Lead sponsor
Shanghai IxCell Biotechnology Co., LTD
Phase
Phase 1
Overall status
Completed
Start date
April 10, 2023
Completion date
August 27, 2024
Enrollment
18 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke